SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-20-001054
Filing Date
2020-04-03
Accepted
2020-04-03 16:13:18
Documents
8
Effectiveness Date
2020-04-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS cvs3650331-defa14a.htm DEFA14A 42288
2 GRAPHIC cvs3650331-defa14a1x2x1.jpg GRAPHIC 9822
3 GRAPHIC cvs3650331-defa14ax1x1.jpg GRAPHIC 9181
4 GRAPHIC cvs3650331-defa14ax1x2.jpg GRAPHIC 2196
5 GRAPHIC cvs3650331-defa14ax2x1.jpg GRAPHIC 7926
6 GRAPHIC cvs3650331-defa14ax2x2.jpg GRAPHIC 2197
7 GRAPHIC cvs3650331-defa14ax3x1.jpg GRAPHIC 2186
8 GRAPHIC cvs3650331-defa14ax4x1.jpg GRAPHIC 2194
  Complete submission text file 0001206774-20-001054.txt   93852
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

IRS No.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-01011 | Film No.: 20773482
SIC: 5912 Retail-Drug Stores and Proprietary Stores
Office of Trade & Services